<abstract xmlns="http://www.w3.org/1999/xhtml">In recent years, the incoming information about the emergence of new superbacteria and superviruses has been causing growing anxiety. However, also fungi are with increasing frequency reported as the sources of intercontinental microbiological hazards. According to the latest reports, quickly spreading, multidrug-resistant and difficult to identify yeast <italic>Candida auris</italic> may soon become the center of attention for clinicians, laboratory diagnosticians and the groups of advisers on the hospital-acquired infections, also in Poland. Unfortunately, the methods employed in routine microbiological diagnostics in the Polish medical laboratories cannot reliably identify this dangerous species. It is, therefore, necessary to implement measures to develop this field.1. Introduction. 2. <italic>Candida</italic> spp. infections. 3. New fungal pathogen–<italic>Candida auris.</italic> 3.1. Epidemiology and pathogenicity. 3.2. Difficulties with identification. 3.3. Virulence factors. 3.4. Drug resistance of <italic>C. auris.</italic> 4. Preventive actions. 5. Summary</abstract>

In recent years, the incoming information about the emergence of new superbacteria and superviruses has been causing growing anxiety. However, also fungi are with increasing frequency reported as the sources of intercontinental microbiological hazards. According to the latest reports, quickly spreading, multidrug-resistant and difficult to identify yeast Candida auris may soon become the center of attention for clinicians, laboratory diagnosticians and the groups of advisers on the hospital-acquired infections, also in Poland. Unfortunately, the methods employed in routine microbiological diagnostics in the Polish medical laboratories cannot reliably identify this dangerous species. It is, therefore, necessary to implement measures to develop this field.1. Introduction. 2. Candida spp. infections. 3. New fungal pathogen–Candida auris. 3.1. Epidemiology and pathogenicity. 3.2. Difficulties with identification. 3.3. Virulence factors. 3.4. Drug resistance of C. auris. 4. Preventive actions. 5. Summary

<italic>Candida auris</italic>– emerging fungal pathogen

Advancements of Microbiology

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

<trans-abstract xml:lang="pl" xmlns="http://www.w3.org/1999/xhtml">1. Wprowadzenie. 2. Zakażenia <italic>Candida</italic> spp. 3. Nowy patogen grzybiczy –<italic>Candida auris.</italic> 3.1. Epidemiologia i chorobotwórczość. 3.2. Problemy identyfikacyjne. 3.3. Czynniki chorobotwórczości. 3.4. Lekooporność szczepów <italic>C. auris.</italic> 4. Działania prewencyjne. 5. Podsumowanie</trans-abstract>

1. Wprowadzenie. 2. Zakażenia Candida spp. 3. Nowy patogen grzybiczy –Candida auris. 3.1. Epidemiologia i chorobotwórczość. 3.2. Problemy identyfikacyjne. 3.3. Czynniki chorobotwórczości. 3.4. Lekooporność szczepów C. auris. 4. Działania prewencyjne. 5. Podsumowanie

In recent years, the incoming information about the emergence of new superbacteria and superviruses has been causing growing anxiety. However, also fungi are...

Candida auris– emerging fungal pathogen

Published Online: May 22, 2019

Page range: 282 - 288

Received: Dec 01, 2016

Accepted: May 01, 2016

DOI: https://doi.org/10.21307/PM-2017.56.3.282

2017 @ Dominika Grondalska., Published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.